| |
| | UNC Department of Pharmacology: Gary L. Johnson |
 | | Witowsky, J.A., Johnson, G.L. Ubiquitylation of MEKK1 inhibits its phosphorylation of MKK1 and MKK4 and activation of the ERK1/2 and JNK pathways. |
 | | Abell, A.M., Knall, C., Ambruso, D.R., Riches, D.W. and Johnson, G. (2003) Rac2 D57N , a dominant negative mutant that inhibits signaling and disrupts the actin cytoskeleton. |
 | | Uhlik, M.T., Abell, A.N., Johnson, N.L., Sun W., Cuevas, B.D., Lobel-Rice,K.E., Horne, E.A., Dell'Acqua, M.L. and Johnson, G.L. (2003) Rac-MEKK3-MKK3 Scaffolding for p38 MAPK Activation During Hyperosmotic Shock Nat, Cell Biol., inpress. |
| www.med.unc.edu /pharm/faculty/johnson.htm (2041 words) |
|